<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: How the drug patent process protects Big Pharma&#8217;s profits</title>
	<atom:link href="/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/feed/" rel="self" type="application/rss+xml" />
	<link>/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/</link>
	<description>Helping Americans get safe access to affordable medications.</description>
	<lastBuildDate>Mon, 06 May 2013 18:36:51 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
	<item>
		<title>By: Health News: Reimportation and Obama's Healthcare Plan &#124; The eDrugSearch Blog</title>
		<link>/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/comment-page-1/#comment-204712</link>
		<dc:creator>Health News: Reimportation and Obama's Healthcare Plan &#124; The eDrugSearch Blog</dc:creator>
		<pubDate>Mon, 02 Mar 2009 10:20:02 +0000</pubDate>
		<guid isPermaLink="false">/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/#comment-204712</guid>
		<description><![CDATA[[...] extending patent monopolies, not creating innovative new treatments. Pharmaceutical companies have gamed the FDA for years by arguing that they deserves short-term monopolies on new drugs as a reward for their innovation. [...]]]></description>
		<content:encoded><![CDATA[<p>[...] extending patent monopolies, not creating innovative new treatments. Pharmaceutical companies have gamed the FDA for years by arguing that they deserves short-term monopolies on new drugs as a reward for their innovation. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dan</title>
		<link>/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/comment-page-1/#comment-150189</link>
		<dc:creator>Dan</dc:creator>
		<pubDate>Sun, 09 Mar 2008 23:22:41 +0000</pubDate>
		<guid isPermaLink="false">/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/#comment-150189</guid>
		<description><![CDATA[The actual molecular entity of a potential pharma candidate of a big pharma company typically is developed in an academic setting not affiliated with the big pharma company.  Then, the company lisences the patent from such an institution to progress with development.  So they are big on development, and limited on research.  So they keep the public in a dreamworld, do they not?]]></description>
		<content:encoded><![CDATA[<p>The actual molecular entity of a potential pharma candidate of a big pharma company typically is developed in an academic setting not affiliated with the big pharma company.  Then, the company lisences the patent from such an institution to progress with development.  So they are big on development, and limited on research.  So they keep the public in a dreamworld, do they not?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dan</title>
		<link>/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/comment-page-1/#comment-150184</link>
		<dc:creator>Dan</dc:creator>
		<pubDate>Sun, 09 Mar 2008 23:10:05 +0000</pubDate>
		<guid isPermaLink="false">/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/#comment-150184</guid>
		<description><![CDATA[Big pharma also does what is called evergreening, which is applying for additional indications on one of thier aged drugs, along with paying off generic drug companies to delay the release of generics of a particular product.]]></description>
		<content:encoded><![CDATA[<p>Big pharma also does what is called evergreening, which is applying for additional indications on one of thier aged drugs, along with paying off generic drug companies to delay the release of generics of a particular product.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: eDrugSearch Blog &#187; Blog Archive &#187; Supreme Court ruling may give generic drugmakers power to challenge bogus Big Pharma patents</title>
		<link>/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/comment-page-1/#comment-41564</link>
		<dc:creator>eDrugSearch Blog &#187; Blog Archive &#187; Supreme Court ruling may give generic drugmakers power to challenge bogus Big Pharma patents</dc:creator>
		<pubDate>Mon, 21 May 2007 15:50:16 +0000</pubDate>
		<guid isPermaLink="false">/edsblog/how-the-drug-patent-process-protects-big-pharmas-profits/#comment-41564</guid>
		<description><![CDATA[[...] Supreme Court ruling may give generic drugmakers power to challenge bogus Big Pharma patents As we&#8217;ve discussed here a number of times, the FDA has long allowed Big Pharma to play games in protecting its brand-name drugs against generic competition. [...]]]></description>
		<content:encoded><![CDATA[<p>[...] Supreme Court ruling may give generic drugmakers power to challenge bogus Big Pharma patents As we&#8217;ve discussed here a number of times, the FDA has long allowed Big Pharma to play games in protecting its brand-name drugs against generic competition. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
